The adenoma-carcinoma sequence ("The great majority of colorectal carcinomas arises from adenomas") proposed by Morson et al (1972) has been generally accepted world wide. Considering the sequence from the viewpoint of human carcinogenesis in general, however, a few contradictions and mysterious phenomena are found in the development and growth process of the colorectal carcinomas. It is evident that the histogenesis of the adenoma-carcinoma sequence including such contradictions is logically false. Consequently, we should fundamentally reconsider the histogenesis of colorectal carcinoma. The premise for the induction of the histogenesis of colorectal carcinoma is that carcinomas are much more objectively differentiated from adenomas with severe atypia, and that hyperplastic glands with slight atypia are differentiated from adenomas with slight atypia. In order to objectify the histological interpretation of atypical grades, conversion of complicated histological designs into real numbers is required. Two discriminant functions with two variables (N/C ratio and density of tubuli in a unit area) for differentiating carcinoma from adenoma have been determined using computed image processing. Based on the discriminant functions for differentiating objectively between carcinoma, adenoma, and hyperplasia, the histogenesis of colorectal carcinomas has been deduced as follows: 70-80% of colorectal carcinomas arise from the colorectal mucosa (de novo carcinoma) and 20-30% arise from adenoma. Observing the various clinicopathological phenomena in colorectal adenomas and carcinomas from the viewpoint of histogenesis, the contradictions do not enter the logically constructed model. Furthermore, the biological behavior of de novo carcinoma is clinicopathologically different from that of carcinoma with the sequence.
Download full-text PDF |
Source |
---|
J Gastrointest Cancer
January 2025
Colorectal Research Center, Imam Khomeini Hospital complex, Tehran University of Medical Sciences, Keshavarz Blvd, Tehran, Iran.
Purpose: Carcinoembryonic antigen (CEA) is an important prognostic factor for rectal cancer. This study aims to introduce a novel cutoff point for CEA within the normal range to improve prognosis prediction and enhance patient stratification in rectal cancer patients.
Methods: A total of 316 patients with stages I to III rectal cancer who underwent surgical tumor resection were enrolled.
Cancer Chemother Pharmacol
January 2025
Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
Purpose: Patients with partial or complete DPD deficiency have decreased capacity to degrade fluorouracil and are at risk of developing toxicity, which can be even life-threatening.
Case: A 43-year-old man with moderately differentiated rectal adenocarcinoma on capecitabine presented to the emergency department with complaints of nausea, vomiting, diarrhea, weakness, and lower abdominal pain for several days. Laboratory findings include grade 4 neutropenia (ANC 10) and thrombocytopenia (platelets 36,000).
BMC Surg
January 2025
Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-Ku, Osaka, 545-8585, Japan.
Background/aim: The effectiveness of a transanal drainage tube (TAT) for the prevention of anastomotic leakage after double stapling technique (DST) anastomosis in colorectal cancer has been reported. Previously, TATs had been placed and connected to drainage bags. It was considered that a higher decompression effect could be expected by inserting an open-type TAT, without connection to a drainage bag.
View Article and Find Full Text PDFBMC Cancer
January 2025
Department of Surgery, Tokushima University, 3-18-15 Kuramoto-Cho, Tokushima, 770-8503, Japan.
The pro-tumor effects of mast cell (MC) in the tumor microenvironment (TME) are becoming increasingly clear. Recently, MC were shown to contribute to tumor malignancy by supporting the migration of tumor-associated macrophages (TAMs), suggesting a relationship with tumor immunity. In the current study, we aimed to examine the correlation between MC infiltration and neoadjuvant chemoradiotherapy (nCRT) response for locally advanced rectal cancer (LARC).
View Article and Find Full Text PDFInt J Colorectal Dis
January 2025
Exact Sciences Corporation, Madison, WI, USA.
Purpose: Colorectal cancer (CRC) is the second leading cause of cancer mortality in the USA and is highly preventable, with early screening vital for improving outcomes. This study aimed to evaluate adherence rates of multi-target stool DNA (mt-sDNA) testing, following updated guidelines recommending screening starting at age 45.
Methods: This retrospective cohort study used aggregated data from Exact Sciences Laboratories LLC, examining new users (first-time testers) aged 45-85 with commercial, Medicare, or Medicaid insurance who received mt-sDNA test kits (point-of-care) between January 1, 2023, and June 1, 2023.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!